Balance Sheet Data
Surface Oncology, Inc. (SURF)
$0.6327
-0.03 (-4.14%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 158.83 | 105.16 | 175.14 | 154.15 | 124.82 | 2,135.99 | 10,497.51 | 51,590.93 | 253,548.12 | 1,246,084.40 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.32 | 0.34 | 2.57 | 0.04 | 0.48 | 2.34 | 11.52 | 56.61 | 278.21 | 1,367.29 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 3.41 | 3.38 | 1.67 | 0.26 | 2.91 | 14.30 | 70.29 | 345.43 | 1,697.66 | 8,343.28 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -2.02 | -1.54 | -0.04 | -0.12 | -0 | -5.28 | -25.96 | -127.57 | -626.93 | -3,081.12 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.